Rewind Therapeutics Competitors and Similar CompaniesClear all
Rewind Therapeutics's competitors and similar companies include JCR Pharmaceuticals, Travere Therapeutics, Kamada Pharmaceuticals and GBT (Global Blood Therapeutics).
 JCR Pharmaceuticals JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products. |  Travere Therapeutics Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. |  Kamada Pharmaceuticals Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications. |  GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. | ||
Founding Date | Founding Date 2017 | Founding Date 1975 | Founding Date 2011 | Founding Date 1990 | Founding Date 2012 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Leuven, BE HQ | Locations Ashiya, JP HQ Kobe, JP Kobe, JP Kobe, JP Kobe, JP | Locations San Diego, US HQ Dublin, IE | Locations Rehovot, IL HQ Beit Kama, IL | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB |
Employees | Employees 196% increase | Employees 934 | Employees 46293% increase | Employees 420 | Employees 352106% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 533.9 m | Valuation ($) 1.4 b | Valuation ($) 317 m | Valuation ($) 4.4 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥33.1b (FY, 2025) | Revenue (est.) $490.7m (FY, 2025) | Revenue (est.) $180.5m (FY, 2025) | Revenue (est.) $194.7m (FY, 2021) |
Cost of goods | Cost of goods N/A | Cost of goods ¥8b (FY, 2025) | Cost of goods $10.3m (FY, 2025) | Cost of goods $72.1m (FY, 2025) | Cost of goods $3.3m (FY, 2021) |
Gross profit | Gross profit N/A | Gross profit ¥25.1b (FY, 2025) | Gross profit $480.4m (FY, 2025) | Gross profit $108.4m (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income (¥4.7b) (FY, 2025) | Net income ($25.5m) (FY, 2025) | Net income $20.2m (FY, 2025) | Net income ($303.1m) (FY, 2021) |
Funding | |||||
Total funding raised | Total funding raised $ 21.5m | Total funding raised N/A | Total funding raised $ 25m | Total funding raised $ 90m | Total funding raised $ 88.7m |
For sources of this data, please see the company profile
View Company Profiles
JCR Pharmaceuticals
HQ
Ashiya, JP
Employees
934
JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products.
View companyTravere Therapeutics
HQ
San Diego, US
Employees
462
Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
View companyKamada Pharmaceuticals
HQ
Rehovot, IL
Employees
420
Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.
View companyGBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View company